Futu News reported on April 14 that the three major indices of Hong Kong stocks all rose, $Hang Seng Index (800000.HK)$ Up 2.40%, $Hang Seng TECH Index (800700.HK)$Up 2.34%, $Hang Seng China Enterprises Index (800100.HK)$Up 2.11%.
As of the closing, 1624 stocks in the Hong Kong market rose, 491 fell, and 1016 closed flat.
The specific industry performance is shown in the picture below:
In terms of sectors, Network Technology stocks rose, Alibaba-W increased by 5.05%, Baidu-SW rose by 3.98%, NTES-S went up by 2.86%, JD-SW increased by 2.45%, TENCENT rose by 2.39%, XIAOMI-W fell by 2.37%, KUAISHOU-W rose by 1.82%, and MEITUAN-W rose by 1.67%.
Biotechnology stocks rose, with INNOVENT BIO increasing by 9.83%, ZAI LAB rising by 9.68%, BEIGENE up by 8.34%, WUXI BIO increasing by 6.32%, AKESO up by 5.78%, WUXI XDC rising by 5.05%, WUXI APPTEC increasing by 3.22%, and JXR falling by 0.92%.
Golden Industrial Concept stocks rose, with TONGGUAN GOLD increasing by 19.17%, SD GOLD rising by 9.85%, LAOPU GOLD up over 7%, ZHAOJIN MINING rising by 6.88%, LINGBAO GOLD up by 6.71%, PERSISTENCE RES increasing by 5.69%, Zijin Mining Group rising by 4.11%, and CHINAGOLDINTL up by 3.69%.
Nonferrous Metals stocks moved upward, with SD GOLD increasing by 9.85%, ZHAOJIN MINING rising by 6.88%, CMOC Group Limited up by 5.32%, JIANGXI COPPER rising by 4.77%, Zijin Mining Group up by 4.11%, Jl Mag Rare-Earth increasing by 1.96%, Aluminum Corporation Of China rising by 1.42%, and CHINAHONGQIAO up by 0.60%.
Pharmaceutical stocks performed well, with HEC CJ PHARM increasing by 10.58%, CSPC PHARMA rising by 9.49%, Hutchmed (China) up by 6.98%, UNITED LAB rising by 6.56%, SINO BIOPHARM increasing by 4.47%, 3SBIO up by 3.71%, INNOVENT BIO rising by 1.36%, and HANSOH PHARMA increasing by 0.88%.
Shipping and Ports stocks rose, with PACIFIC BASIN increasing by 5.52%, OOIL rising by 4.99%, COSCO Shipping Holdings up by 3.74%, Qingdao Port International rising by 3.47%, DEXIN Marine Transportation up by 3.24%, CHINA MER PORT increasing by 2.77%, SITC rising by 2.63%, and COSCO SHIP ENGY up by 1.80%.
In terms of individual stocks,$STANCHART (02888.HK)$Increased by over 6%, Morgan Stanley pointed out that its short-term valuation has become more attractive.
$GIANT BIOGENE (02367.HK)$Increased by nearly 10%, reaching a record high, the company stated that its resume products do not contain EGF, and the flagship product drives high growth in revenue and profit.
$ANHUIEXPRESSWAY (00995.HK)$Increased by nearly 4%, planning to raise over 0.5 billion Hong Kong dollars through a rights issue to major shareholders, the company released its shareholder return plan.
$TCL ELECTRONICS (01070.HK)$Increased by nearly 2%, recently released a new round of Stock-based Incentive plan, the company continues to improve its global industrial layout.
$HKEX (00388.HK)$A rise of nearly 7%, the price adjustment may have already reflected the tariff risks, with North water and policy support providing support for Hong Kong stocks.
$J&T EXPRESS-W (01519.HK)$An increase of over 3%, with the first quarter package volume growing 26.5% year-on-year to 4.985 billion units, higher than the industry average growth rate.
$GANFENGLITHIUM (01772.HK)$An increase of over 4%, having signed a memorandum of understanding with LAR for the joint development of the Argentine PPGS lithium salt lake project.
Top 10 transaction amounts today.
Hong Kong Stock Connect funds.
In terms of Hong Kong Stock Connect, there was a net inflow of 5.784 billion Hong Kong dollars today.
Institutional Views
Citi has raised the target price for ZHAOJIN MINING to 21.6 Hong Kong dollars and adjusted the profit forecast for this year and next.
Citi published a report indicating that its commodity team expects prices to remain high in the short term and to outperform other metals. The bank mentioned, $ZHAOJIN MINING (01818.HK)$the profit is highly correlated with gold prices, and based on the bank's base case (i.e., 3,000 US dollars per ounce), ZHAOJIN MINING's net profit will rise by 10% for every 5% increase in gold prices. The bank expects the company's self-operated mining capacity to reach 174 tons this year, raising the profit forecast for ZHAOJIN MINING for this year and next by 50% and 23% respectively, and estimating profits will reach 4.8 billion yuan by 2027, adjusting the target price from 18.9 Hong Kong dollars to 21.6 Hong Kong dollars, with a rating of "Buy.
Morgan Stanley: Upgraded BYD's rating to Overweight, target price raised to 438 Hong Kong dollars.
Morgan Stanley stated that against the backdrop of trade tensions, weak global economy, and rapid development of AI, $BYD COMPANY (01211.HK)$The quality, speed of innovation, and scale may allow it to transform cyclical downturns into structural increases. Morgan Stanley upgraded BYD's rating from in line with the market to Buy. The target price was raised from HKD 307 to HKD 438. The reason is that BYD is expected to contribute more than 30% to global electric vehicle growth by 2025, with a projected compound annual growth rate of 10% to 12% in sales over the next five years, and is expected to rival Toyota in sales by 2030.
Goldman Sachs: Slightly lowered the target price for GANFENGLITHIUM H shares to HKD 18.9, maintaining a 'Neutral' rating.
Goldman Sachs published Research Reports stating, $GANFENGLITHIUM (01772.HK)$ Last year’s performance fell short of the bank's expectations but met Bloomberg's expectations. During the period, there was a net loss of 2.07 billion yuan, with recurring profits down 96% year-on-year. The bank stated that due to a continued overabundance of supply, it maintains a negative outlook on lithium supply/demand and price prospects, keeping a 'Neutral' rating on GANFENGLITHIUM H shares. The target price was slightly adjusted down from HKD 19 to HKD 18.9.
Editor/danial
